Terns Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Terns Pharmaceuticals, a clinical-stage biopharmaceutical company (Nasdaq: TERN), is set to present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, at 2:00 p.m. ET. The company focuses on developing small-molecule therapies for serious diseases, including oncology, obesity, and non-alcoholic steatohepatitis (NASH). Interested investors can access a live audio webcast of the presentation on Terns' investor relations page, with a replay available for 30 days post-event.

FOSTER CITY, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that management will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14 at 2:00 p.m. ET.

A live audio webcast of the presentation will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for 30 days following the presentation.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and NASH. Terns’ pipeline includes four clinical stage development programs including an allosteric BCR-ABL inhibitor, a THR-β agonist, an FXR agonist, a VAP-1 inhibitor, and a preclinical small-molecule GLP-1 receptor agonist program. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com

Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com

FAQ

When is Terns Pharmaceuticals presenting at the H.C. Wainwright conference?

Terns Pharmaceuticals will present on September 14, 2022, at 2:00 p.m. ET.

How can I listen to Terns Pharmaceuticals' presentation live?

The presentation can be accessed via live audio webcast on the Terns investor relations page.

What diseases is Terns Pharmaceuticals focusing on?

Terns Pharmaceuticals is developing treatments for oncology, obesity, and non-alcoholic steatohepatitis (NASH).

What is the stock symbol for Terns Pharmaceuticals?

The stock symbol for Terns Pharmaceuticals is TERN.

Will there be a replay of Terns Pharmaceuticals' presentation?

Yes, a replay of the presentation will be available on Terns' website for 30 days after the event.